LAMPIRE provides specialized support for monoclonal and polyclonal antibody development targeting oligonucleotide and antisense therapeutics. With more than a decade of experience in this challenging immunogen class, customized immunization and purification strategies are designed to generate highly sensitive and specific anti-oligonucleotide antibodies.

Tailored approaches address low immunogenicity and purification complexity through optimized carrier conjugation, refined immunization protocols, and custom affinity purification workflows, supporting drug development, assay development, and therapeutic monitoring applications.